Superior Planning, LLC’s BioNTech BNTX Stock Holding History

Superior Planning, LLC’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.65K	Buy	+27	New	+$2.62K	﹤0.01%	1463

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Davern Capital Partners Ny, New York $514M AUM 16.9% 1-Year Est. Return

GSK plc London $497M AUM 35.1% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Superior Planning, LLC's BNTX Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in BioNTech (BNTX) in Q3 2026: 27 shares worth $2.65K. The stake represents ﹤0.01% of the portfolio and ranks #1463 among its holdings.

184 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

Superior Planning, LLC held 27 shares of BioNTech worth $2.65K as of Q3 2026.
BioNTech was a new Superior Planning, LLC position in Q3 2026.
BioNTech made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1463 holding.
184 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.